Jounce Therapeutics to Present at Upcoming Investor Conferences in June
June 11, 2019 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., June 11, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
January 30, 2019 07:30 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s leading...
Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
January 25, 2019 09:01 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s leading...
HotSchedules Recognized by JMP Securities as a “Hot 100” Software Company
September 04, 2018 09:56 ET
|
HotSchedules
AUSTIN, Texas and ATLANTA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- HotSchedules®, the leading provider of workforce and back office solutions for the restaurant, retail and hospitality industries, today...
Sonatype Named to JMP Securities’ 2018 Hot 100 List
August 03, 2018 11:01 ET
|
Sonatype
FULTON, MD, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Sonatype, the leader in automated open source governance, today announced it has been named to the JMP Securities’ Hot 100 list of the hottest privately...
VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
June 19, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Sienna Biopharmaceuticals to Present at JMP Securities Life Science Conference
June 14, 2018 09:05 ET
|
Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief...
TrueCar to Participate in Upcoming Conferences
February 21, 2018 19:33 ET
|
TrueCar, Inc.
SANTA MONICA, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- TrueCar, Inc. (NASDAQ:TRUE) announced today that management will attend the following conferences: Morgan Stanley Technology, Media &...
HCI Group to Participate at the JMP Securities Insurance Forum on Tuesday, November 15, 2016
November 08, 2016 16:15 ET
|
HCI Group, Inc.
TAMPA, Fla., Nov. 08, 2016 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners’ insurance, with additional operations in reinsurance, real estate and...
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference June 21, 2016
June 14, 2016 16:15 ET
|
Minerva Neurosciences, Inc.
WALTHAM, Mass., June 14, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...